Nasdaq:US$15.99 (+0.35) | HKEX:HK$24.75 (+0.65) | AIM:£2.49 (+0.01)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 3 Oct 2013

Analyst briefing on Chi-Med’s pharmaceutical R&D business on 9 October 2013